CLINICAL_TRIALS
trial_result
· 2017-10-13
Clinical Trial Update: The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation [Phase 4]
Summary
This update notes the completion of the Phase 4 Contact PVI trial evaluating tissue-contact data to guide atrial fibrillation ablation. The study is sponsored b…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Oxford University Hospitals NHS Trust | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED